BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Cempra Pharmaceuticals, Inc. Doses First Patients in Solithromycin (CEM-101) Phase 2 Trial in Uncomplicated Urogenital Gonococcal Infections

  June 12, 2012

   · 

  4 min read
• Genetown

  Acorda Therapeutics to Present at Wells Fargo 2012 Healthcare Conference

  June 12, 2012

   · 

  1 min read
• Drug Development

  Tokai Pharmaceuticals’ Galeterone Receives Fast Track Designation from the FDA for the Treatment of Advanced Prostate Cancer

  June 12, 2012

   · 

  1 min read
• BioCapital

  ParagonRx Webinar to Provide Insight on the Institute of Medicine’s Report Titled, Ethical and Scientific Issues in Studying the Safety of Approved Drugs

  June 12, 2012

   · 

  1 min read
• Pharm Country

  FDA Commissioner Margaret Hamburg to Speak at Drug Information Association 2012 48th Annual Meeting

  June 12, 2012

   · 

  1 min read
• Genetown

  Biogen Idec, Inc. (Massachusetts) to Highlight Innovative Pipeline and Commercial Strategy

  June 12, 2012

   · 

  1 min read
• BioMidwest

  University of Michigan Health System Release: Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Don’t Damage Hearing

  June 12, 2012

   · 

  5 min read
• Business

  Aegis Analytical Corporation Teams up with Sequence

  June 12, 2012

   · 

  1 min read
• Drug Development

  Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. Present Data at the 72nd Boehringer Ingelheim Pharmaceuticals, Inc. Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine

  June 12, 2012

   · 

  11 min read
• Drug Development

  Greer Labs Reports Positive Findings from Large Phase III Clinical Trial Evaluating Sublingual Immunotherapy for Ragweed Allergies

  June 12, 2012

   · 

  1 min read